In the present study, it was found that there was a higher post-operative level of MIP-3α (POD 180) and a relatively higher adjuvant chemotherapy rate NSCLC patients (post-operative histopathological stage I or II) with recurrence or metastasis. Here, CCL20 is linked to non-small cell lung carcinoma.